188 related articles for article (PubMed ID: 25619721)
1. Enhanced antitumor effects of the BRBP1 compound peptide BRBP1-TAT-KLA on human brain metastatic breast cancer.
Fu B; Long W; Zhang Y; Zhang A; Miao F; Shen Y; Pan N; Gan G; Nie F; He Y; Zhang J; Teng G
Sci Rep; 2015 Jan; 5():8029. PubMed ID: 25619721
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of a novel phage display-derived peptide with affinity for human brain metastatic breast cancer.
Fu B; Zhang Y; Long W; Zhang A; Zhang Y; An Y; Miao F; Nie F; Li M; He Y; Zhang J; Teng G
Biotechnol Lett; 2014 Nov; 36(11):2291-301. PubMed ID: 25048232
[TBL] [Abstract][Full Text] [Related]
3. Enhanced targeted anticancer effects and inhibition of tumor metastasis by the TMTP1 compound peptide TMTP1-TAT-NBD.
Liu R; Xi L; Luo D; Ma X; Yang W; Xi Y; Wang H; Qian M; Fan L; Xia X; Li K; Wang D; Zhou J; Meng L; Wang S; Ma D
J Control Release; 2012 Aug; 161(3):893-902. PubMed ID: 22580115
[TBL] [Abstract][Full Text] [Related]
4. Co-administration of kla-TAT peptide and iRGD to enhance the permeability on A549 3D multiple sphere cells and accumulation on xenograft mice.
Hu C; Chen X; Huang Y; Chen Y
Chem Biol Drug Des; 2018 Aug; 92(2):1567-1575. PubMed ID: 29722179
[TBL] [Abstract][Full Text] [Related]
5. Tumor-penetrating peptide fused to a pro-apoptotic peptide facilitates effective gastric cancer therapy.
Huang Y; Li X; Sha H; Zhang L; Bian X; Han X; Liu B
Oncol Rep; 2017 Apr; 37(4):2063-2070. PubMed ID: 28260064
[TBL] [Abstract][Full Text] [Related]
6. The use of electronic-neutral penetrating peptides cyclosporin A to deliver pro-apoptotic peptide: A possibly better choice than positively charged TAT.
Gao W; Yang X; Lin Z; He B; Mei D; Wang D; Zhang H; Zhang H; Dai W; Wang X; Zhang Q
J Control Release; 2017 Sep; 261():174-186. PubMed ID: 28662902
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional Liposomes Enable Active Targeting and Twinfilin 1 Silencing to Reverse Paclitaxel Resistance in Brain Metastatic Breast Cancer.
Du J; Shao Y; Hu Y; Chen Y; Cang J; Chen X; Pei W; Miao F; Shen Y; Muddassir M; Zhang Y; Zhang J; Teng G
ACS Appl Mater Interfaces; 2021 May; 13(20):23396-23409. PubMed ID: 33982563
[TBL] [Abstract][Full Text] [Related]
8. iRGD-targeted delivery of a pro-apoptotic peptide activated by cathepsin B inhibits tumor growth and metastasis in mice.
Qifan W; Fen N; Ying X; Xinwei F; Jun D; Ge Z
Tumour Biol; 2016 Aug; 37(8):10643-52. PubMed ID: 26867766
[TBL] [Abstract][Full Text] [Related]
9. Bladder tumor-targeted delivery of pro-apoptotic peptide for cancer therapy.
Jung HK; Kim S; Park RW; Park JY; Kim IS; Lee B
J Control Release; 2016 Aug; 235():259-267. PubMed ID: 27282414
[TBL] [Abstract][Full Text] [Related]
10. The cell penetrating ability of the proapoptotic peptide, KLAKLAKKLAKLAK fused to the N-terminal protein transduction domain of translationally controlled tumor protein, MIIYRDLISH.
Kim HY; Kim S; Youn H; Chung JK; Shin DH; Lee K
Biomaterials; 2011 Aug; 32(22):5262-8. PubMed ID: 21565400
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of the pro-apoptosis peptide kla-TAT and the cationic anticancer peptide HPRP-A1.
Hu C; Chen X; Huang Y; Chen Y
Apoptosis; 2018 Feb; 23(2):132-142. PubMed ID: 29397453
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide.
Tan M; Lan KH; Yao J; Lu CH; Sun M; Neal CL; Lu J; Yu D
Cancer Res; 2006 Apr; 66(7):3764-72. PubMed ID: 16585203
[TBL] [Abstract][Full Text] [Related]
13. Targeted NIRF/MR dual-mode imaging of breast cancer brain metastasis using BRBP1-functionalized ultra-small iron oxide nanoparticles.
Du J; Zhang Y; Jin Z; Wu H; Cang J; Shen Y; Miao F; Zhang A; Zhang Y; Zhang J; Teng G
Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111188. PubMed ID: 32806329
[TBL] [Abstract][Full Text] [Related]
14. Targeting brain tumors by intra-arterial delivery of cell-penetrating peptides: a novel approach for primary and metastatic brain malignancy.
Joshi S; Cooke JRN; Ellis JA; Emala CW; Bruce JN
J Neurooncol; 2017 Dec; 135(3):497-506. PubMed ID: 28875440
[TBL] [Abstract][Full Text] [Related]
15. Coadministration of kla peptide with HPRP-A1 to enhance anticancer activity.
Hao W; Hu C; Huang Y; Chen Y
PLoS One; 2019; 14(11):e0223738. PubMed ID: 31703065
[TBL] [Abstract][Full Text] [Related]
16. Cell-Penetrating Peptide-Modified Gold Nanoparticles for the Delivery of Doxorubicin to Brain Metastatic Breast Cancer.
Morshed RA; Muroski ME; Dai Q; Wegscheid ML; Auffinger B; Yu D; Han Y; Zhang L; Wu M; Cheng Y; Lesniak MS
Mol Pharm; 2016 Jun; 13(6):1843-54. PubMed ID: 27169484
[TBL] [Abstract][Full Text] [Related]
17. Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer.
Liang AL; Qian HL; Zhang TT; Zhou N; Wang HJ; Men XT; Qi W; Zhang PP; Fu M; Liang X; Lin C; Liu YJ
Drug Des Devel Ther; 2015; 9():5671-86. PubMed ID: 26527862
[TBL] [Abstract][Full Text] [Related]
18. A novel cell-penetrating peptide suppresses breast tumorigenesis by inhibiting β-catenin/LEF-1 signaling.
Hsieh TH; Hsu CY; Tsai CF; Chiu CC; Liang SS; Wang TN; Kuo PL; Long CY; Tsai EM
Sci Rep; 2016 Jan; 6():19156. PubMed ID: 26750754
[TBL] [Abstract][Full Text] [Related]
19. Influence of TAT-peptide polymerization on properties and transfection activity of TAT/DNA polyplexes.
Soundara Manickam D; Bisht HS; Wan L; Mao G; Oupicky D
J Control Release; 2005 Jan; 102(1):293-306. PubMed ID: 15653153
[TBL] [Abstract][Full Text] [Related]
20. The effect of mTOR inhibition alone or combined with MEK inhibitors on brain metastasis: an in vivo analysis in triple-negative breast cancer models.
Zhao H; Cui K; Nie F; Wang L; Brandl MB; Jin G; Li F; Mao Y; Xue Z; Rodriguez A; Chang J; Wong ST
Breast Cancer Res Treat; 2012 Jan; 131(2):425-36. PubMed ID: 21394501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
